Press Release: Source Los Alamos National Laboratory

Biomagnetics to Accelerate Availability of the World’s First Integrated Optical Biosensor for Malaria, Cholera, TB and HIV/AIDS Diagnosis Wednesday Feb 10, 09:00 AM ET

SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed. This strategy is expected to significantly accelerate the availability of this life and cost saving technology. The Los Alamos triggered optical biosensor is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors. These devices are specifically designed to be battery operated and ultraportable, allowing for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting.

The Company’s initial strategy was to fully produce the handheld version of the IOBS platform and to then use that platform to develop all of the many different types of pathogen testing assay cartridges. By taking a slightly different direction and developing desktop versions of the IOBS platform, which can be produced more quickly, the Company will be able to develop the single test assay cartridges for malaria, cholera, human tuberculosis, bovine tuberculosis and HIV/AIDS in parallel to the production of the handheld units. This approach will significantly reduce time-to-market and make this important technology available to the world much sooner and will allow the corporation to accelerate its revenue growth rate.

About Biomagnetics Diagnostics Corp

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s revolutionary diagnostic systems, which are based on advanced magnetic and optics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test via traditional existing methodologies. More information on Biomagnetics Diagnostics Corp. can be seen at www.BiomagneticsBMGP.com.

Contacts:
Biomagnetics Diagnostics Corp.
Joe Noel, 925-922-2560